Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ E.W. Scripps (SSP) Q3 2026 Earnings Call Transcript (Fool) +++ SCRIPPS Aktie +3,04%

GLOBUS MEDICAL Aktie

 >GLOBUS MEDICAL Aktienkurs 
64.56 EUR    -11.1%    (TradegateBSX)
Ask: 64.9 EUR / 400 Stück
Bid: 64.36 EUR / 400 Stück
Tagesumsatz: 261 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
GLOBUS MED Aktie über LYNX handeln
>GLOBUS MEDICAL Performance
1 Woche: +7,1%
1 Monat: +14,1%
3 Monate: +10,9%
6 Monate: +1,4%
1 Jahr: +45,2%
laufendes Jahr: +3,4%
>GLOBUS MEDICAL Aktie
Name:  GLOBUS MEDICAL
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US3795772082 / A1J2LY
Symbol/ Ticker:  GM0N (Frankfurt) / GMED (NYSE)
Kürzel:  FRA:GM0N, ETR:GM0N, GM0N:GR, NYSE:GMED
Index:  -
Profil:  Globus Medical Inc. Class A Common Stock represents ownership in Globus Medical, a medical device company focused on musculoskeletal care. The company develops and commercializes products for spine and orthopaedic applications, including implant syst..
>Volltext..
Marktkapitalisierung:  10425.34 Mio. EUR
Unternehmenswert:  10001.82 Mio. EUR
Umsatz:  2803.7 Mio. EUR
EBITDA:  854.03 Mio. EUR
Nettogewinn:  477.33 Mio. EUR
Gewinn je Aktie:  3.54 EUR
Schulden:  99.77 Mio. EUR
Liquide Mittel:  452.65 Mio. EUR
Operativer Cashflow:  811.61 Mio. EUR
Bargeldquote:  1.24
Umsatzwachstum:  23.51%
Gewinnwachstum:  54.85%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  1 Insider verkaufte innerhalb der letzten 30 Tage Aktien im Wert von 379.695 Euro.
Suchwörter:  GLOBUS MEDICAL, GLOBUS MED
Letzte Datenerhebung:  06.11.26
>GLOBUS MED Kennzahlen
Aktien/ Unternehmen:
Aktien: 111.83 Mio. St.
Frei handelbar: 99.26%
Rückkaufquote: 0.94%
Mitarbeiter: 6000
Umsatz/Mitarb.: 0.44 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 17.88%
Bewertung:
KGV: 22.26
KGV lG: 17.11
KUV: 3.44
KBV: 2.45
PEG-Ratio: 0.4
EV/EBITDA: 11.71
Rentabilität:
Bruttomarge: 64.9%
Gewinnmarge: 17.03%
Operative Marge: 21.53%
Managementeffizenz:
Gesamtkaprendite: 10.25%
Eigenkaprendite: 11.81%
>GLOBUS MED Peer Group
Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege
 
06.11.26 - 18:24
Globus Medical bricht zweistellig ein: Umsatzenttäuschung und Prognosesenkung drücken Aktie auf 52-Wochen-Tief (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
06.11.26 - 17:30
GMED Q3 Earnings Call Highlights Guidance Cut and 2027 Reset (Zacks)
 
Globus Medical cuts its 2026 revenue outlook amid spine launch delays and weak Nevro sales while shifting its focus to new products and growth opportunities in 2027....
06.11.26 - 08:24
Globus Medical (GMED) Q3 2026 Earnings Call Transcript (Fool)
 
Record free cash flow offset a revenue dip and a lower full-year outlook....
06.11.26 - 03:00
Compared to Estimates, Globus Medical (GMED) Q3 Earnings: A Look at Key Metrics (Zacks)
 
The headline numbers for Globus Medical (GMED) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals....
06.11.26 - 02:48
Globus Medical lowers 2026 revenue outlook to $3.09B while reiterating non-GAAP EPS of $4.95-$5.05 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
06.11.26 - 02:01
Insiderhandel: Aufsichtsrat verkauft Aktien von Globus Medical im Wert von 425000 USD (Insiderkauf)
 
Rhoads, Ann D. - Aufsichtsrat - Tag der Transaktion: 2026-11-04...
06.11.26 - 01:01
Globus Medical (GMED) Q3 Earnings Top Estimates (Zacks)
 
Globus Medical (GMED) delivered earnings and revenue surprises of +2.50% and -3.69%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?...
05.11.26 - 22:42
Globus Medical Non-GAAP EPS of $1.23 beats by $0.03, revenue of $763.7M misses by $28.76M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.26 - 22:03
Globus Medical Reports Third Quarter 2026 Results and Announces a $500 Million Increase to the Share Repurchase Program (GlobeNewswire EN)
 
Globus Medical reported Q3 2026 financial results, reflecting disciplined execution and continued focus on strategic priorities....
21.10.26 - 22:30
Kuehn Law Encourages Investors of Globus Medical, Inc. to Contact Law Firm (PR Newswire)
 
NEW YORK, Oct. 21, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Globus Medical, Inc. (NYSE: GMED) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing.......
14.10.26 - 14:01
Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026 (GlobeNewswire EN)
 
New Innovations Designed to Advance Patient-Specific Planning and Connected Surgical Workflows New Innovations Designed to Advance Patient-Specific Planning and Connected Surgical Workflows...
12.10.26 - 22:03
Globus Medical Schedules Third Quarter Earnings Release and Conference Call (GlobeNewswire EN)
 
AUDUBON, Pa., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the third quarter ended September 30, 2026 after the market close on Thursday, November 5, 2026. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com....
07.10.26 - 17:30
Reasons to Add Globus Medical Stock to Your Portfolio Now (Zacks)
 
GMED gains musculoskeletal share on strong spine and trauma growth, while product innovation and a debt-free balance sheet support its appeal....
06.10.26 - 09:00
Zacks Industry Outlook Globus Medical, Intuitive Surgical and Thermo Fisher Scientific (Zacks)
 
Globus Medical, Intuitive Surgical and Thermo Fisher Scientific have been highlighted in this Industry Outlook article....
17.09.26 - 04:01
Insiderhandel: Aufsichtsrat verkauft Aktien von Globus Medical im Wert von 2237502 USD (Insiderkauf)
 
Tobin, James R. - Aufsichtsrat - Tag der Transaktion: 2026-09-15...
16.09.26 - 19:45
What Makes Globus Medical (GMED) a New Strong Buy Stock (Zacks)
 
Globus Medical (GMED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy)....
10.09.26 - 11:30
Zacks Industry Outlook Highlights Veracyte, Globus Medical and UFP Technologies (Zacks)
 
Veracyte, Globus Medical and UFP Technologies are positioned to benefit as GenAI adoption reshapes medical instruments....
10.09.26 - 10:45
Zacks.com featured highlights include Globus Medical, NetApp and Assurant (Zacks)
 
Globus Medical, NetApp and Assurant stand out for strong projected sales growth as investors navigate renewed Middle East tensions....
09.09.26 - 16:00
3 Sales Growth Stocks to Buy Amid Renewed Middle East Tensions (Zacks)
 
Globus Medical, NetApp and Assurant stand out for sustainable sales growth, strong cash flow and favorable valuation and profitability screens....
04.09.26 - 14:15
Globus Medical granted CE mark for mobile X-ray system in Europe (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Müßiggang ist des Teufels Ruhebank. - Sprichwort Deutschland
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!